ARTICLE SUMMARY:
Cardiovascular disease is as prevalent as ever, yet cardiologists and advanced imaging resources remain relegated to major hospitals. UltraSight combines proprietary AI with vetted clinical expertise to enhance the average clinician's ability to render quality images from handheld probes and interpret them with accuracy, bringing access to high-level care to a greater population than ever before.
In 2018, UltraSight Ltd. (originally OnSight Medical) was forged as a joint venture between deep technology AI experts at the Weizmann Institute of Science and experienced clinicians at the NYU Langone Medical Center with the objective to yield informative cardiac sonography from a handheld ultrasound probe regardless of operator skill level.
